Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Díaz-Almirón M[au]:

Search results

Items: 24

1.

Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH).

Pérez-Martínez A, Ferreras C, Pascual A, Gonzalez-Vicent M, Alonso L, Badell I, Fernández Navarro JM, Regueiro A, Plaza M, Pérez Hurtado JM, Benito A, Beléndez C, Couselo JM, Fuster JL, Díaz-Almirón M, Bueno D, Mozo Y, Marsal J, Gómez López A, Sisinni L, de Heredia CD, Díaz MÁ.

Am J Hematol. 2019 Oct 17. doi: 10.1002/ajh.25661. [Epub ahead of print]

PMID:
31625177
2.

Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients.

Trilla-Fuertes L, Gámez-Pozo A, Díaz-Almirón M, Prado-Vázquez G, Zapater-Moros A, López-Vacas R, Nanni P, Zamora P, Espinosa E, Fresno Vara JÁ.

Future Oncol. 2019 Oct;15(30):3483-3490. doi: 10.2217/fon-2018-0698. Epub 2019 Oct 3.

PMID:
31580166
3.

Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities.

Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, Zapater-Moros A, Díaz-Almirón M, Arevalillo JM, Ferrer-Gómez M, Navarro H, Maín P, Espinosa E, Pinto Á, Vara JÁF.

BMC Cancer. 2019 Jun 28;19(1):636. doi: 10.1186/s12885-019-5858-z.

4.

Melanoma proteomics suggests functional differences related to mutational status.

Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, Zapater-Moros A, Díaz-Almirón M, Fortes C, Ferrer-Gómez M, López-Vacas R, Parra Blanco V, Márquez-Rodas I, Soria A, Fresno Vara JÁ, Espinosa E.

Sci Rep. 2019 May 10;9(1):7217. doi: 10.1038/s41598-019-43512-z.

5.

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.

Prado-Vázquez G, Gámez-Pozo A, Trilla-Fuertes L, Arevalillo JM, Zapater-Moros A, Ferrer-Gómez M, Díaz-Almirón M, López-Vacas R, Navarro H, Maín P, Feliú J, Zamora P, Espinosa E, Fresno Vara JÁ.

Sci Rep. 2019 Feb 7;9(1):1538. doi: 10.1038/s41598-018-38364-y.

6.

Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?

Osorio-Silla I, Gómez Valdazo A, Sánchez Méndez JI, York E, Díaz-Almirón M, Gómez Ramírez J, Rivas Fidalgo S, Oliver JM, Álvarez CM, Hardisson D, Díaz Miguel M, Lobo F, Díaz Domínguez J.

Ann R Coll Surg Engl. 2019 Mar;101(3):186-192. doi: 10.1308/rcsann.2018.0196. Epub 2018 Nov 13.

PMID:
30421628
7.

Predictors of asthma relapse in patients who attended an emergency department.

Pola-Bibian B, Dominguez-Ortega J, Vilà-Nadal G, Entrala A, González-Cavero L, Barranco P, Cancelliere N, Díaz-Almirón M, Quirce S.

Allergy Asthma Proc. 2018 Jul 1;39(4):292-298. doi: 10.2500/aap.2018.39.4130.

PMID:
30095395
8.

Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer.

Zapater-Moros A, Gámez-Pozo A, Prado-Vázquez G, Trilla-Fuertes L, Arevalillo JM, Díaz-Almirón M, Navarro H, Maín P, Feliú J, Zamora P, Espinosa E, Fresno Vara JÁ.

Oncotarget. 2018 Jun 12;9(45):27586-27594. doi: 10.18632/oncotarget.25496. eCollection 2018 Jun 12.

9.

How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?

Fernández L, Leivas A, Valentín J, Escudero A, Corral D, de Paz R, Vela M, Bueno D, Rodríguez R, Torres JM, Díaz-Almirón M, López-Collazo E, Martinez-Lopez J, Pérez-Martínez A.

Transfusion. 2018 Jun;58(6):1340-1347. doi: 10.1111/trf.14573. Epub 2018 Mar 14.

PMID:
29542132
10.

Molecular characterization of breast cancer cell response to metabolic drugs.

Trilla-Fuertes L, Gámez-Pozo A, Arevalillo JM, Díaz-Almirón M, Prado-Vázquez G, Zapater-Moros A, Navarro H, Aras-López R, Dapía I, López-Vacas R, Nanni P, Llorente-Armijo S, Arias P, Borobia AM, Maín P, Feliú J, Espinosa E, Fresno Vara JÁ.

Oncotarget. 2018 Jan 8;9(11):9645-9660. doi: 10.18632/oncotarget.24047. eCollection 2018 Feb 9.

11.

Impact of Iliac Instrumentation on the Quality of Life of Patients With Adult Spine Deformity.

Martín-Buitrago MP, Pizones J, Sánchez Pérez-Grueso FJ, Díaz Almirón M, Vila-Casademunt A, Obeid I, Alanay A, Kleinstück F, Acaroglu ER, Pellisé F; ESSG European Spine Study Group.

Spine (Phila Pa 1976). 2018 Jul 1;43(13):913-918. doi: 10.1097/BRS.0000000000002476.

PMID:
29095408
12.

Increasing survival of metastatic breast cancer through locoregional surgery.

Díaz de la Noval B, Frías Aldeguer L, Ángeles Leal García M, García López E, Díaz Almirón M, Herrera de la Muela M.

Minerva Ginecol. 2018 Feb;70(1):44-52. doi: 10.23736/S0026-4784.17.04097-7. Epub 2017 Oct 9.

PMID:
28994557
13.

Clinical and microbiological profile of infectious keratitis in an area of Madrid, Spain.

Mediero S, Boto de Los Bueis A, Spiess K, Díaz-Almirón M, Del Hierro Zarzuelo A, Villalaín Rodes I, García Perea A.

Enferm Infecc Microbiol Clin. 2018 Aug - Sep;36(7):409-416. doi: 10.1016/j.eimc.2017.08.002. Epub 2017 Oct 6. English, Spanish.

PMID:
28993066
14.

Functional proteomics outlines the complexity of breast cancer molecular subtypes.

Gámez-Pozo A, Trilla-Fuertes L, Berges-Soria J, Selevsek N, López-Vacas R, Díaz-Almirón M, Nanni P, Arevalillo JM, Navarro H, Grossmann J, Gayá Moreno F, Gómez Rioja R, Prado-Vázquez G, Zapater-Moros A, Main P, Feliú J, Martínez Del Prado P, Zamora P, Ciruelos E, Espinosa E, Fresno Vara JÁ.

Sci Rep. 2017 Aug 30;7(1):10100. doi: 10.1038/s41598-017-10493-w.

15.

Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.

Gámez-Pozo A, Trilla-Fuertes L, Prado-Vázquez G, Chiva C, López-Vacas R, Nanni P, Berges-Soria J, Grossmann J, Díaz-Almirón M, Ciruelos E, Sabidó E, Espinosa E, Fresno Vara JÁ.

PLoS One. 2017 Jun 8;12(6):e0178296. doi: 10.1371/journal.pone.0178296. eCollection 2017.

16.

Body composition analysis and adipocytokine concentrations in haemodialysis patients: abdominal fat gain as an additional cardiovascular risk factor.

González E, Díez JJ, Pérez Torres A, Bajo MA, Del Peso G, Sánchez-Villanueva R, Grande C, Rodríguez O, Coronado M, Gómez Candela C, Díaz-Almirón M, Iglesias P, Selgas R.

Nefrologia. 2017 Mar - Apr;37(2):138-148. doi: 10.1016/j.nefro.2016.06.007. Epub 2016 Oct 27. English, Spanish.

17.

Asthma exacerbations in a tertiary hospital: clinical features, triggers, and risk factors for hospitalization.

Pola-Bibian B, Dominguez-Ortega J, Vilà-Nadal G, Entrala A, González-Cavero L, Barranco P, Cancelliere N, Díaz-Almirón M, Quirce S.

J Investig Allergol Clin Immunol. 2016 Dec 14:0. doi: 10.18176/jiaci.0128. [Epub ahead of print]

18.

Does the Profile of Sensitization to Grass Pollen Allergens Have Clinical Relevance?

Palao-Ocharan P, Domínguez-Ortega J, Barranco P, Diaz-Almiron M, Quirce S.

J Investig Allergol Clin Immunol. 2016;26(3):188-9. doi: 10.18176/jiaci.0043. No abstract available.

19.

Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria-A Follow-Up.

Ferrer-Santacreu EM, Ortiz-Cruz EJ, Díaz-Almirón M, Pozo Kreilinger JJ.

J Oncol. 2016;2016:8262079. doi: 10.1155/2016/8262079. Epub 2016 Feb 23.

20.

Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications.

González E, Díez JJ, Bajo MA, del Peso G, Grande C, Rodríguez O, Díaz-Almirón M, Iglesias P, Selgas R.

PLoS One. 2016 Mar 17;11(3):e0151698. doi: 10.1371/journal.pone.0151698. eCollection 2016.

21.

Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.

Sendagorta E, Bernardino JI, Álvarez-Gallego M, Feíto M, Feltes R, Beato MJ, Pérez-Molina JA, Yllescas M, Díaz-Almirón M, Arribas JR, González-García J, Herranz P; CIDAN127412 GESIDA Study Group.

AIDS. 2016 Jan 2;30(1):75-82. doi: 10.1097/QAD.0000000000000886.

PMID:
26731755
22.

An Increase of Plasma Advanced Oxidation Protein Products Levels Is Associated with Cardiovascular Risk in Incident Peritoneal Dialysis Patients: A Pilot Study.

Gonzalez E, Bajo MA, Carrero JJ, Lindholm B, Grande C, Sánchez-Villanueva R, Del Peso G, Díaz-Almirón M, Iglesias P, Díez JJ, Selgas R.

Oxid Med Cell Longev. 2015;2015:219569. doi: 10.1155/2015/219569. Epub 2015 Oct 25.

23.

Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications.

Gámez-Pozo A, Berges-Soria J, Arevalillo JM, Nanni P, López-Vacas R, Navarro H, Grossmann J, Castaneda CA, Main P, Díaz-Almirón M, Espinosa E, Ciruelos E, Fresno Vara JÁ.

Cancer Res. 2015 Jun 1;75(11):2243-53. doi: 10.1158/0008-5472.CAN-14-1937. Epub 2015 Apr 16.

24.

Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.

Torres JM, Martinez-Barricarte R, García-Gómez S, Mazariegos MS, Itan Y, Boisson B, Rholvarez R, Jiménez-Reinoso A, del Pino L, Rodríguez-Pena R, Ferreira A, Hernández-Jiménez E, Toledano V, Cubillos-Zapata C, Díaz-Almirón M, López-Collazo E, Unzueta-Roch JL, Sánchez-Ramón S, Regueiro JR, López-Granados E, Casanova JL, Pérez de Diego R.

J Clin Invest. 2014 Dec;124(12):5239-48. doi: 10.1172/JCI77493. Epub 2014 Nov 3.

Supplemental Content

Loading ...
Support Center